Phytochemicals and callus suspension culture as cancer therapeutics

Mathewos Geneto Abiche1,2, Vinay Kumar3, Wusirika Ramakrishna1

  • 1Department of Biochemistry, School of Basic Sciences, Central University of Punjab, VPO-Ghudda, Bathinda, India.

Insights

Medicinal plant compounds from callus cultures show potent anticancer effects by inducing apoptosis and targeting key cancer pathways. These plant-derived compounds offer a promising, less toxic alternative to conventional cancer treatments.

Area of Science:

  • Pharmacology
  • Plant Biotechnology
  • Oncology

Background:

  • Cancer necessitates novel, less toxic, and affordable therapies.
  • Herbal medicines and natural products offer promising anticancer agents.
  • Bioactive compounds exhibit diverse mechanisms, including apoptosis induction and pathway inhibition.

Purpose of the Study:

  • To review the anticancer properties and mechanisms of bioactive compounds from medicinal plants.
  • To discuss the potential of callus suspension culture-derived metabolites as anticancer agents.
  • To highlight the advantages of callus cultures over traditional plant extraction.

Main Methods:

  • Review of in vitro studies on anticancer properties of plant-derived compounds.
  • Analysis of mechanisms of action, including apoptosis induction and cell cycle arrest.
  • Evaluation of callus suspension culture technology for metabolite production.

Main Results:

  • Callus-derived compounds demonstrated superior efficacy compared to whole-plant extracts and chemotherapeutics in vitro.
  • Mechanisms include p53 upregulation, altered Bcl-2/Bax ratio, caspase activation, and G2/M cell cycle arrest.
  • Callus cultures provide consistent, scalable, pathogen-free production of novel metabolites.

Conclusions:

  • Callus suspension cultures are a promising technology for producing potent anticancer agents.
  • These plant-derived compounds offer a less toxic alternative to conventional treatments.
  • Challenges include bioavailability, limited clinical data, quality control, and regulatory hurdles.